Brian Rha

Brian Rha

Auto-generated profile, based on publicly available information

Brian Rha

Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Pediatrics
Verified
Journal Article
Closed access
PDF file
BRBrian Rha
Brian Rha
ACAaron T. Curns
Aaron T. Curns
JLJoana Y. Lively
Joana Y. Lively
ACAngela P. Campbell
Angela P. Campbell
JEJanet A. Englund
Janet A. Englund
SGSusan I. Gerber
Susan I. Gerber
BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of hospitalized acute respiratory illness (ARI) among young children. With RSV vaccines and immunoprophylaxis agents in clinical development, we sought to update estimates of US pediatric RSV hospitalization burden. METHODS: Children <5 years old hospitalized for ARI were enrolled through active, prospective, population-based surveillance from November 1, 2015, to June 30, 2016, at 7 US pediatric hospital sites. Clinical information was obtained from parent interviews and medical records. Midturbinate nasal and throat flocked swabs were collected and tested for RSV by using molecular diagnostic assays at each site. We conducted descriptive analyses and calculated population-based rates of RSV-associated hospitalizations. RESULTS: Among 2969 hospitalized children included in analyses, 1043 (35%) tested RSV-positive; 903 (87%) children who were RSV-positive were <2 years old, and 526 (50%) were <6 months old. RSV-associated hospitalization rates were 2.9 per 1000 children <5 years old and 14.7 per 1000 children <6 months old; the highest age-specific rate was observed in 1-month-old infants (25.1 per 1000). Most children who were infected with RSV (67%) had no underlying comorbid conditions and no history of preterm birth. CONCLUSIONS: During the 2015–2016 season, RSV infection was associated with one-third of ARI hospitalizations in our study population of young children. Hospitalization rates were highest in infants <6 months. Most children who were RSV-positive had no history of prematurity or underlying medical conditions, suggesting that all young children could benefit from targeted interventions against RSV.

6 January 2014 in Expert Review of Vaccines
Verified
Journal Article
Closed access
BRBrian Rha
Brian Rha
JTJacqueline E Tate
Jacqueline E Tate
DPDaniel C Payne
Daniel C Payne
MCMargaret M Cortese
Margaret M Cortese
BLBenjamin A Lopman
Benjamin A Lopman
UPUmesh D Parashar
Umesh D Parashar
Prior to the introduction of rotavirus vaccines in 2006, rotavirus was the leading cause of severe gastroenteritis among US children <5 years of age. In the first 7 years of vaccine use, both recommended rotavirus vaccines (RotaTeq [RV5] and Rotarix [RV1]) have been shown to be highly effective in preventing outcomes of severe disease in US children in a variety of settings. In addition, substantial decreases in severe diarrheal disease in US children, exceeding the level expected based on vaccine coverage, as well as the extension of benefits to older age groups ineligible for vaccination have demonstrated both the direct and indirect impacts of vaccination in the USA.

12 July 2014 in Expert Review of Vaccines
Verified
Journal Article
Closed access
BRBrian Rha
Brian Rha
JTJacqueline E Tate
Jacqueline E Tate
EWEric Weintraub
Eric Weintraub
PHPenina Haber
Penina Haber
CYCatherine Yen
Catherine Yen
UPUmesh D Parashar
Umesh D Parashar
In 1999, the first rotavirus vaccine licensed in the USA was withdrawn 9 months after introduction due to an association with intussusception that was detected in post-licensure surveillance. This association prompted large clinical trials designed to ensure the safety of two current live oral rotavirus vaccines, RotaTeq and Rotarix, which have since been recommended for use worldwide. Following their introduction, post-licensure studies have focused not only on the effectiveness and impact of these vaccines, but also on continued surveillance for intussusception. Most recent evidence from several countries shows a small increased risk of intussusception following vaccination with Rotarix and RotaTeq within the context of their demonstrated benefits. This review summarizes the available data on the safety of rotavirus vaccines with regards to intussusception.

21 June 2018 in Journal of the Pediatric Infectious Diseases Society
Verified
Journal Article
Open access
PDF file
BRBrian Rha
Brian Rha
RDRebecca M Dahl
Rebecca M Dahl
JMJocelyn Moyes
Jocelyn Moyes
ABAlison M Binder
Alison M Binder
STStefano Tempia
Stefano Tempia
CCCheryl Cohen
Cheryl Cohen
Analyses of hospital-based sentinel surveillance for acute lower respiratory infection in children aged <5 years in South Africa revealed that a fever-based case definition for severe acute respiratory infection had low sensitivity for identifying RSV-positive cases, particularly in young infants.

1 August 2013 in Emerging Infectious Diseases
Verified
Journal Article
Open access
BRBrian Rha
Brian Rha
SBSherry Burrer
Sherry Burrer
SPSoyoun Park
Soyoun Park
TTTarak Trivedi
Tarak Trivedi
UPUmesh D. Parashar
Umesh D. Parashar
BLBenjamin A. Lopman
Benjamin A. Lopman
Noroviruses are the leading cause of gastroenteritis in the United States, but timely measures of disease are lacking. BioSense, a national-level electronic surveillance system, assigns data on chief complaints (patient symptoms) collected during emergency department (ED) visits to 78 subsyndromes in near real-time. In a series of linear regression models, BioSense visits mapped by chief complaints of diarrhea and nausea/vomiting subsyndromes as a monthly proportion of all visits correlated strongly with reported norovirus outbreaks from 6 states during 2007–2010. Higher correlations were seen for diarrhea (R = 0.828–0.926) than for nausea/vomiting (R = 0.729–0.866) across multiple age groups. Diarrhea ED visit proportions exhibited winter seasonality attributable to norovirus; rotavirus contributed substantially for children <5 years of age. Diarrhea ED visit data estimated the onset, peak, and end of norovirus season within 4 weeks of observed dates and could be reliable, timely indicators of norovirus activity.

1 April 2017 in Journal of Clinical Virology
Verified
Journal Article
Closed access
MAMohammad Mousa Al-Abdallat
Mohammad Mousa Al-Abdallat
BRBrian Rha
Brian Rha
SASultan Alqasrawi
Sultan Alqasrawi
DPDaniel C. Payne
Daniel C. Payne
IIIbrahim Iblan
Ibrahim Iblan
SGSusan I. Gerber
Susan I. Gerber